Clinical trial Recruiting at 1 site Interventional Ages 18 to 45

Unilateral M1 Anodal tDCS to Help Learning a Beat Saber Game

Official title: Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task

Run by Indiana University · NCT07447882 · Data updated 2026-11-12

This study tests whether applying anodal tDCS to the motor cortex can help healthy adults learn a Beat Saber game faster.

Quick facts

Study typeInterventional
Ages18 Years to 45 Years
SexAll
Enrollment52 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Indianapolis, Indiana)
StatusRecruiting
StartedApril 23, 2025
Main results expectedAugust 2026
Study endsAugust 2026
Registry record updatedJune 1, 2026
Trial IDNCT07447882 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Healthy adults aged 18-45 without neurological or significant medical issues affecting the upper limbs.

Probably not a fit

Individuals with certain neurological conditions, ongoing stimulant use, or factors increasing tDCS risk may not benefit and could be excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a between-subjects, SHAM-controlled study in healthy adults to see if motor cortex stimulation with anodal tDCS enhances motor learning during a virtual reality game. Participants are randomized to active or sham stimulation while playing Beat Saber across two sessions about 24 hours apart. Each session includes a practice block with stimulation, followed by pre- and post-assessments using the game’s performance metrics. The goal is to observe whether brain stimulation accelerates learning of a gross upper-limb motor task in a VR setting, with future work to examine underlying cortical changes.

Why it matters

Potential benefit: If successful, this approach could offer a noninvasive way to boost motor learning in tasks requiring large-arm movements using VR tasks.

How similar studies have gone: Previous work combining VR with brain stimulation for rehabilitation is emerging, but this specific motor-learning pairing in VR is among the first focused on learning speed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* · Healthy adults between the ages 18-45

  * Answer 'no' to questions 2 through 18 on the tDCS checklist as these factors can increase likelihood of adverse events with tDCS (Appendix 1)

    * No neurological damage, disease, or dysfunction (nerve damage, chronic pain disorders, diabetic neuropathy) that affect the upper limbs.
    * No significant acute or chronic medical, neurologic, or illness in the patient that, in the judgment of the Principal Investigator, could compromise subject safety, limit the ability to complete the study, and/or compromise the objectives of the study

Exclusion Criteria:

* · Currently prescribed and taking stimulant medication (Adderall, Ritalin, Vyvanse, etc.)

  * Consumption of over-the-counter stimulants such as caffeine or nicotine (coffee, soda, supplements, energy drinks, tobacco products, or other nicotine containing products such as gum, vape pens, etc...) 12 hours prior to entering the lab on the day of testing as this can directly affect cortical excitability. If a subject takes any of these substances 12 hours prior to session 1 they will be asked to reschedule for a later date.
  * Have played the game Beat Saber on a Virtual Reality Headset in the last 12 months.

Where it's running

  • National Institute for Fitness and Sport
    Indianapolis, Indiana, United States
    Recruiting

Study contacts

  • Principal investigator: zachary riley — Indiana University
  • Study coordinator: zachary riley
  • Email: zariley@iu.edu
  • Phone: 765-215-1487

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.